Amgen and AstraZeneca report positive results of Phase IIb asthma trial

Amgen and AstraZeneca have reported positive results from a Phase IIb clinical trial (PATHWAY) of tezepelumab to treat patients with severe uncontrolled asthma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news